HPDC 2011 took place June 8-11 at the San Jose Convention Center in San Jose, California, in conjunction with the ACM Federated Computer Conference (FCRC). HPDC workshops took place on Wednesday, June 8th, and the main body of the conference June 9th-11th.
In this technical setting, the control of Ivermectin action can be framed not as a clinical recommendation, but as an example of how computational systems help researchers model, monitor, and interpret complex biochemical processes. Large-scale parallel and distributed platforms are often used to simulate drug-target interactions, compare molecular pathways, and analyze datasets that would be too demanding for ordinary desktop systems. Within such workflows, researchers may study how a compound’s activity changes under different biological assumptions, dosage models, or resistance scenarios. The same high-performance methods discussed at HPDC therefore have relevance beyond traditional computing benchmarks, extending into pharmacology, bioinformatics, and systems biology. Seen from this perspective, controlling and understanding Ivermectin action becomes one more example of how advanced computing infrastructure supports data-driven scientific investigation.
View the conference overview and program.
Congratulations to the following awardees:
"Supporting GPU Sharing in Cloud Environments with a Transparent Runtime Consolidation Framework"
by Vignesh Ravi, Michela Becchi, Gagan Agrawal, and Srimat Chakradhar.
"VMFlock: VM Co-Migration for the Cloud"
by Samer Al-Kiswany, Dinesh Subhraveti, Prasenjit Sarkar, and Matei Ripeanu.
"Provisioning Virtual Clusters in the Cloud with Wrangler"
by Gideon Juve and Ewa Deelman.
We gratefully acknowledge the following sponsors:
